Literature DB >> 10682314

Increased urine heparan and chondroitin sulphate excretion in patients with osteopetrosis.

R D Steiner1, M P Whyte, E Chang, J Hanks, C Mattes, H Senephansiri, K M Gibson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10682314     DOI： 10.1023/a:1005663200288

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  5 in total

1.  Localization of a gene for autosomal dominant osteopetrosis (Albers-Schönberg disease) to chromosome 1p21.

Authors:  W Van Hul; J Bollerslev; J Gram; E Van Hul; W Wuyts; O Benichou; F Vanhoenacker; P J Willems
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

2.  Structure, chromosomal location, and expression profile of EXTR1 and EXTR2, new members of the multiple exostoses gene family.

Authors:  T Saito; N Seki; M Yamauchi; S Tsuji; A Hayashi; S Kozuma; T Hori
Journal:  Biochem Biophys Res Commun       Date:  1998-02-04       Impact factor: 3.575

3.  The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate.

Authors:  C McCormick; Y Leduc; D Martindale; K Mattison; L E Esford; A P Dyer; F Tufaro
Journal:  Nat Genet       Date:  1998-06       Impact factor: 38.330

4.  Human autosomal recessive osteopetrosis maps to 11q13, a position predicted by comparative mapping of the murine osteosclerosis (oc) mutation.

Authors:  C Heaney; H Shalev; K Elbedour; R Carmi; J B Staack; V C Sheffield; D R Beier
Journal:  Hum Mol Genet       Date:  1998-09       Impact factor: 6.150

5.  Abnormal urinary excretion of glycosaminoglycans in Albers-Schönberg disease.

Authors:  F Marcucci; S Rufini; L Sensi
Journal:  Clin Chim Acta       Date:  1982-04-08       Impact factor: 3.786
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.